Ring finger protein 32 (RNF32)

Ring finger protein 32 (RNF32) is a zinc-binding protein containing two RING-H2 finger domains, separated by an IQ domain of unknown function, and is classified as a RING finger protein[1][2][6][14]. RING finger motifs are involved in protein-DNA and protein-protein interactions and are characteristic of E3 ubiquitin ligases, which play important roles in post-translational modification of target proteins[1][2][12]. RNF32 is specifically expressed in testis (primarily during spermatogenesis, likely in spermatocytes and/or spermatids), suggesting a possible role in sperm formation[1][2][6][14]. RNF32 is not currently recognized as a major therapeutic target, nor are there any known drugs that interact with it, but its protein domain organization is likely relevant to protein modification and reproductive biology[1][2][14]. RNF32 encodes a protein with a unique double RING-H2 domain structure, a first described in this gene[1][8]. Expression is testis and ovary-specific in humans and appears related to germ cell development[1][6][14]. No evidence has been found to classify RNF32 as a receptor, enzyme, transporter, or current therapeutic target in the literature or pharmaceutical databases[6][13][14]. No drugs, biomarkers, or established mechanisms of action have been reported for RNF32. There are no notable safety concerns or therapeutic challenges documented[6][13][14]. Some genetic association studies have connected RNF32 to rare inherited disorders, but causal biological mechanisms remain unclear and it is not an established marker or target for these diseases[6]. If a specific therapeutic or mechanistic context emerges, some re-assessment would be warranted, but currently, RNF32 is best described as a testis-expressed, double RING finger domain-containing protein implicated in spermatogenesis.

Other names

FKSG33HSD15LMBR2